Moon-Kyoung Bae Selected Research

PD 168368

11/2021	Neuromedin B modulates phosphate-induced vascular calcification.
9/2016	Neuromedin B receptor antagonism inhibits migration, invasion, and epithelial-mesenchymal transition of breast cancer cells.
12/2011	Neuromedin B receptor antagonist suppresses tumor angiogenesis and tumor growth in vitro and in vivo.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Moon-Kyoung Bae Research Topics

Disease

11	Neoplasms (Cancer) 10/2014 - 01/2003
8	Hypoxia (Hypoxemia) 02/2014 - 01/2002
7	Inflammation (Inflammations) 02/2021 - 05/2008
7	Breast Neoplasms (Breast Cancer) 09/2016 - 07/2006
3	Vascular Calcification 11/2021 - 01/2020
3	Periodontitis 12/2020 - 02/2013
3	Glioblastoma (Glioblastoma Multiforme) 09/2009 - 03/2006
2	Chronic Renal Insufficiency 11/2021 - 01/2020
2	Neoplasm Metastasis (Metastasis) 03/2019 - 09/2016
2	Obesity 02/2012 - 05/2008
2	Vascular Diseases (Vascular Disease) 07/2010 - 05/2008
1	Periodontal Diseases (Periodontal Disease) 01/2021
1	Infections 12/2020
1	Liver Cirrhosis (Hepatic Cirrhosis) 01/2020
1	Heart Failure 01/2020
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2020
1	Chronic Disease (Chronic Diseases) 01/2020
1	Chronic Periodontitis 01/2020
1	Alveolar Bone Loss 01/2020
1	Multiple Myeloma 03/2019
1	Osteoporosis 03/2019
1	Bisphosphonate-Associated Osteonecrosis of the Jaw 03/2019
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2014
1	Lung Neoplasms (Lung Cancer) 10/2014
1	Pheochromocytoma 10/2011
1	Pathologic Neovascularization 02/2011
1	Brain Neoplasms (Brain Tumor) 09/2009
1	Hepatocellular Carcinoma (Hepatoma) 06/2006
1	Hyperthermia 04/2006
1	Gliosis 03/2006

Drug/Important Bio-Agent (IBA)

10	Proteins (Proteins, Gene)FDA Link 01/2020 - 02/2006
7	Messenger RNA (mRNA)IBA 01/2020 - 03/2006
7	Nicotinamide PhosphoribosyltransferaseIBA 07/2014 - 07/2006
5	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 02/2014 - 01/2002
3	PD 168368IBA 11/2021 - 12/2011
3	Phosphates (Orthophosphate)IBA 11/2021 - 01/2020
3	Bombesin Receptors (Bombesin Receptor)IBA 09/2016 - 12/2011
3	AdipokinesIBA 10/2013 - 05/2008
3	CurcuminIBA 08/2013 - 06/2006
2	neuromedin BIBA 11/2021 - 12/2011
2	calcium phosphateIBA 11/2021 - 01/2020
2	Gastrin-Releasing PeptideIBA 12/2020 - 01/2020
2	CalciumIBA 12/2020 - 01/2020
2	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 01/2020 - 10/2013
2	BombesinIBA 12/2011 - 11/2009
2	Peptides (Polypeptides)IBA 12/2011 - 11/2009
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 11/2009 - 01/2003
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 09/2009 - 03/2006
2	NF-kappa B (NF-kB)IBA 04/2009 - 03/2006
1	SaltsIBA 11/2021
1	AntioxidantsIBA 02/2021
1	CytokinesIBA 01/2021
1	Cysteine Proteases (Cysteine Protease)IBA 01/2021
1	Cathepsin KIBA 01/2021
1	NeuropeptidesIBA 12/2020
1	Mitogen-Activated Protein KinasesIBA 01/2020
1	RNA (Ribonucleic Acid)IBA 01/2020
1	Extracellular Matrix ProteinsIBA 01/2020
1	Connective Tissue Growth FactorIBA 01/2020
1	Biological ProductsIBA 01/2020
1	Tpi(6)-Leu(13)-psi(CH2NH)-Leu(14)- bombesin (6-14)IBA 01/2020
1	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 01/2020
1	diphosphoric acid (pyrophosphoric acid)IBA 03/2019
1	Diphosphonates (Bisphosphonates)IBA 03/2019
1	PTX3 proteinIBA 12/2018
1	Biomarkers (Surrogate Marker)IBA 12/2018
1	VimentinIBA 09/2016
1	Cadherins (E-Cadherin)IBA 09/2016
1	ErbB Receptors (EGF Receptor)IBA 10/2014
1	geldanamycinIBA 10/2014
1	Gefitinib (Iressa)FDA Link 10/2014
1	Tyrosine Kinase InhibitorsIBA 10/2014
1	18-dehydroxyl-17-demethoxyreblastatinIBA 10/2014
1	beta-thujaplicinIBA 02/2014
1	MelatoninIBA 10/2013
1	LipopolysaccharidesIBA 02/2013
1	ChromatinIBA 01/2013
1	ElementsIBA 01/2013
1	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 02/2011
1	ThromboxanesIBA 07/2010
1	ProstaglandinsIBA 07/2010
1	Cell Adhesion MoleculesIBA 04/2009
1	LuciferasesIBA 07/2006
1	Angiogenesis Inducing Agents (Angiogenesis Factor)IBA 06/2006
1	theasinensin AIBA 04/2006
1	trichostatin A (A 300)IBA 04/2006
1	Therapeutic UsesIBA 04/2006
1	Histone Deacetylase InhibitorsIBA 04/2006
1	Glial Fibrillary Acidic ProteinIBA 03/2006
1	Lysine (L-Lysine)FDA Link 02/2006
1	Tissue Inhibitor of Metalloproteinase-3IBA 03/2003
1	GelatinasesIBA 03/2003
1	EnzymesIBA 01/2002
1	Erythropoietin FDA Link 01/2002
1	Oxygen (Dioxygen)IBA 01/2002
1	Transcription Factors (Transcription Factor)IBA 01/2002

Therapy/Procedure

2	Therapeutics 02/2012 - 01/2003
1	Ligation 12/2020
1	Drug Therapy (Chemotherapy) 04/2006
1	Radiotherapy 04/2006